The correlation of genetic instability of PINX1 gene to clinico-pathological features of gastric cancer in the Chinese population.
OBJECTIVE
This project explored the influence of loss of heterozygosity (LOH) and microsatellite instability (MSI) of locus D8S277 to PINX1 expression of gastric cancer in Chinese people.


METHODS
LOH and MSI of locus D8S277 in 90 paraffin-embedded gastric carcinoma specimens were detected by polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP). Envision immunohistochemistry was used to assess the expression of PINX1.


RESULTS
The frequency of LOH was higher in cases with lymph node metastasis than those without (18.57 vs. 0.00%, P < 0.01), and was higher in the specimens that were at TNM stage III + IV than those at stage I + II (21.43 vs. 2.94%, P < 0.01). In terms of the frequency of MSI, it was lower in cases with lymph node metastasis than those without (10.00 vs. 30.00%,P < 0.05). The positive rate of PINX1 protein was higher in samples without lymph node metastasis than those with lymph node metastasis (80.00 vs. 50.00%, P < 0.01); and was higher in the cases at TNM stage I + II than those at stage III + IV; and was lower in the cases between 40 and 60 years old than those above 60 years old (43.75 vs. 65.52%, P < 0.05).


CONCLUSIONS
LOH and MSI of PINX1 may play major role in tumor development and regulate it through different pathways. Because LOH plays a major role in negative expression of PINX1, it can be regarded as a sign of gastric cancer development and MSI may affect the prognosis and tumor turnover.
Ma
Yingyu
Y
Institute of Cell Biology, Zhejiang University, 310058, Hangzhou, China.
Wu
Liang
L
Liu
Cuiping
C
Xu
Liqian
L
Li
Dongmei
D
Li
Ji-Cheng
JC
D044466:Asian People / Q000235:genetics; D018797:Cell Cycle Proteins; D002454:Cell Differentiation; D002681:China / Q000208:ethnology; D043171:Chromosomal Instability; D002874:Chromosome Mapping; D017931:DNA Primers; D004273:DNA, Neoplasm / Q000235:genetics; D005260:Female; D006801:Humans; D019656:Loss of Heterozygosity; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D018807:Polymorphism, Single-Stranded Conformational; D013274:Stomach Neoplasms / Q000235:genetics* / Q000473:pathology*; D025521:Tumor Suppressor Proteins / Q000235:genetics*
D018797:Cell Cycle Proteins; D017931:DNA Primers; D004273:DNA, Neoplasm; C440808:PINX1 protein, human; D025521:Tumor Suppressor Proteins
Cell. 2001 Nov 2;107(3):347-59
11701125
Cancer Lett. 2002 Apr 25;178(2):199-207
11867205
Oncol Rep. 2004 Oct;12(4):861-6
15375513
Cancer Res. 1992 Oct 1;52(19):5368-72
1356616
World J Gastroenterol. 2008 Jan 7;14(1):70-5
18176964
Prostate. 2004 Sep 1;60(4):298-302
15264240
Jpn J Cancer Res. 1993 Aug;84(8):893-9
8407553
Zhonghua Yi Xue Za Zhi. 2006 Jun 27;86(24):1662-5
16854315
Int J Cancer. 2004 Mar 20;109(2):309-14
14750185
Oncol Rep. 2004 Apr;11(4):871-4
15010887
J Gastroenterol. 2000;35 Suppl 12:111-5
10779229
Cancer Res. 2001 Nov 15;61(22):8085-8
11719432
Hepatology. 2000 Oct;32(4 Pt 1):721-7
11003615
Oncogene. 2005 Jan 6;24(1):157-64
15637589
Am J Pathol. 2001 Feb;158(2):527-35
11159189